Evidence map›Paper›PMID 37420765›Full record

ArticleSensors (Basel, Switzerland)2023

Single Modality vs. Multimodality: What Works Best for Lung Cancer Screening?

Joana Vale Sousa, Pedro Matos, Francisco Silva, Pedro Freitas, Hélder P Oliveira, Tania Pereira

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joana Vale SousaInstitute for Systems and Computer Engineering, Technology and Science (INESC TEC), 4200-465 Porto, Portugal.ORCID 0000-0003-1563-2978
Pedro MatosFaculty of Engineering (FEUP), University of Porto, 4200-465 Porto, Portugal.
Francisco SilvaInstitute for Systems and Computer Engineering, Technology and Science (INESC TEC), 4200-465 Porto, Portugal.ORCID 0000-0003-3069-2282
Pedro FreitasInstitute for Systems and Computer Engineering, Technology and Science (INESC TEC), 4200-465 Porto, Portugal.ORCID 0000-0002-4588-5880
Hélder P OliveiraInstitute for Systems and Computer Engineering, Technology and Science (INESC TEC), 4200-465 Porto, Portugal.ORCID 0000-0002-6193-8540
Tania PereiraInstitute for Systems and Computer Engineering, Technology and Science (INESC TEC), 4200-465 Porto, Portugal.ORCID 0000-0003-1681-2436

Funding

Component 5 - Capitalization and Business Innovation, integrated in the Resilience Dimension of the Recovery and Resilience Plan within the scope of the Recovery and Resilience Mechanism (MRR) of the European Union (EU), framed in the Next Generation EU, 2021.05767.BD
6 · The paper itself

Abstract

In a clinical context, physicians usually take into account information from more than one data modality when making decisions regarding cancer diagnosis and treatment planning. Artificial intelligence-based methods should mimic the clinical method and take into consideration different sources of data that allow a more comprehensive analysis of the patient and, as a consequence, a more accurate diagnosis. Lung cancer evaluation, in particular, can benefit from this approach since this pathology presents high mortality rates due to its late diagnosis. However, many related works make use of a single data source, namely imaging data. Therefore, this work aims to study the prediction of lung cancer when using more than one data modality. The National Lung Screening Trial dataset that contains data from different sources, specifically, computed tomography (CT) scans and clinical data, was used for the study, the development and comparison of single-modality and multimodality models, that may explore the predictive capability of these two types of data to their full potential. A ResNet18 network was trained to classify 3D CT nodule regions of interest (ROI), whereas a random forest algorithm was used to classify the clinical data, with the former achieving an area under the ROC curve (AUC) of 0.7897 and the latter 0.5241. Regarding the multimodality approaches, three strategies, based on intermediate and late fusion, were implemented to combine the information from the 3D CT nodule ROIs and the clinical data. From those, the best model-a fully connected layer that receives as input a combination of clinical data and deep imaging features, given by a ResNet18 inference model-presented an AUC of 0.8021. Lung cancer is a complex disease, characterized by a multitude of biological and physiological phenomena and influenced by multiple factors. It is thus imperative that the models are capable of responding to that need. The results obtained showed that the combination of different types may have the potential to produce more comprehensive analyses of the disease by the models.

Indexed as

Lung NeoplasmsArtificial IntelligenceEarly Detection of CancerHumansLungTomography, X-Ray Computedclinical dataCT scandeep learningfeature fusionlung cancermultimodality

Identifiers

PMID37420765
PMCPMC10301640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.